Tag: contract development and manufacturing organisation

BioCina Pty Ltd, a global Contract Development and Manufacturing Organisation (CDMO), has launched a comprehensive manufacturing program for RLS-2201, a proprietary injectable formulation of Quetiapine being developed by Patrys Ltd (ASX: PAB) for the acute treatment of delirium in intensive care. 

BioCina, a biologics Contract Development and Manufacturing Organisation (CDMO), has joined hands with NovaCina, a global fill-and-finish CDMO, to establish a strategic alliance aimed at offering integrated drug substance and drug product solutions for biologics developers.

Nourish Ingredients, an Australian food tech company, is kickstarting manufacturing operations in Singapore as part of a strategic expansion to scale up its potent fat production. 

Australian contract development and manufacturing organisation (CDMO) BioCina has received an AUD 5 million grant under the Federal Government's Medical Research Future Fund (MRFF) Grants scheme to develop enabling technologies for the manufacture of precision mRNA vaccines.

Global private investment firm Bridgewest Group has completed the acquisition of the Perth sterile injectable manufacturing facility from Pfizer. 

Australian contract development and manufacturing organisation (CDMO) BioCina has appointed Mark Womack as the chief executive officer who will be responsible for the continued growth, commercial strategy and organisational culture of the company.